MediFind found 87 doctor with experience in Primitive Neuroectodermal Tumor (PNET) near Durham, NC. Of these, 57 are Experienced, 16 are Advanced and 14 are Distinguished.
Duke Health Integrated Practice Inc
Peter Fecci is a Neurosurgery specialist and a General Surgeon in Durham, North Carolina. Dr. Fecci is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Brain Tumor, Metastatic Brain Tumor, Glioblastoma, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Fecci is currently accepting new patients.
Duke Cancer Center Brain Tumor Clinic
What we specialize in at The Preston Robert Tisch Brain Tumor Center is compassionate care – we take care of our patients. It’s complete care. The patients don’t have to go out and find a radiologist. We have the radiation oncologist, the chemotherapy, the surgery, the radiology, we have all kinds of nursing people as well as help getting physical therapy and getting in-the-home assistance. Patients also can expect cutting-edge care because we run such a terrific science program here. I really like working with the patients. No question about it. It’s not that I’m doing some trivial procedure six times a day. When someone comes in with a brain tumor, there’s usually some bonding, and instead of running away from that, I really enjoy it. Dr. Friedman is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Astrocytoma, Glioma, Glioblastoma, Awake Craniotomy, and Laminectomy.
Duke Cancer Center
I'm a radiation oncologist, and I specialize in treating brain, base of skull and spine tumors, as well as tumors that arise in the body but go to the brain or the spine, as in certain cases of lung, breast and kidney cancer and melanoma. When I meet with a patient, it’s important for me to introduce them and their family to our team of doctors, therapists, nurses and treatment planners. The patient and their family will also become members of this team – truly the most important part - so we can work together to tailor care based on their wants and needs. At Duke, we’ve developed techniques to precisely and accurately treat small, complex lesions and tumors. We can minimize the amount of radiation that goes into normal tissues and at the same time maximize the amount of radiation where it is needed. Our team is geared to delivering every treatment to each patient exactly as planned, especially in complicated and difficult situations. As a patient or a physician, I think there’s no better place to be than Duke. I love my work, feel honored that my patients place their trust in our team and me and work hard to earn that trust. Dr. Kirkpatrick is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Brain Tumor, Meningioma, Glioma, Astrocytoma, and Gamma Knife Radiosurgery.
Duke Cancer Center
I am a medical oncologist who specializes in the treatment of patients with skin cancer. I am part of a team of surgical oncologists, dermatologists, and radiation oncologists who all work together to determine the best treatment approach for each patient. My focus is on treating patients with advanced melanoma, as well as melanoma that is at high risk for recurrence after surgery. We also treat patients with merkel cell carcinoma and advanced basal cell and cutaneous squamous cell carcinoma. We also have a number of clinical trial options available, allowing our patients access to the newest therapies available. Dr. Salama is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Primitive Neuroectodermal Tumor (PNET).
Duke Cancer Center
I am a neurologist and cancer doctor who treats brain tumors and researches ways to improve quality of life for brain tumor patients. As a college student, I thought I was going to be a scientist, but fell in love with studying the brain and its inner workings. I enjoy being at Duke, because I work with some of the top clinicians and researchers in the field, and a generous and warm-hearted staff that helps patients and their loved ones through treatment. It is hard to pick one thing I enjoy about my job. I enjoy seeing patients and their loved ones, being at the cutting edge of research and teaching the next generation of doctors. I think it is the chance to do so many different things that makes my job special. Outside of work, I enjoy shopping at farmer’s markets, cooking and exercising. I also collect Swatch watches - I have over 400!. Dr. Peters is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Glioblastoma, Gliosarcoma, and Neuroepithelioma.
Duke Cancer Center
My primary focus is patient care and clinical research. My clinical research focuses on providing innovative and aggressive therapies to adults with primary brain tumors. I always keep the patient's quality of life foremost in my practice. I completed my residency in adult neurology at the University of Sherbrooke in Quebec. I finished a two-year fellowship in neuro-oncology at The Preston Robert Tisch Brain Tumor Center at Duke. Upon completion of my fellowship in 2005, I joined the Center as faculty. I am a fellow of the Royal College of Physicians of Canada. Dr. Desjardins is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Gliosarcoma, Embryonal Tumor with Multilayered Rosettes, Glioblastoma, and Atypical Teratoid Rhabdoid Tumor (ATRT).
Duke Cancer Center
Above all, I value relationships with family and friends. I have seen the devastation that brain tumors cause to ruin these vital relationships. Therefore, I strive to eradicate brain tumors with the best patient care I can and hard work in the laboratory. It is my hope that we will effectively fight brain tumors and preserve relationships. Dr. Floyd is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Brain Tumor, Glioblastoma, Astrocytoma, and Metastatic Brain Tumor.
Duke Cancer Center
I am an academic adult and pediatric neuro-oncologist who helps lead The Preston Robert Tisch Brain Tumor Center at Duke. I am the author of more than 500 peer-reviewed articles, reviews, and book chapters, and I have presented extensively at both international and national meetings. I am a committed educator who is a member of the executive and super-executive committees of the Duke University School of Medicine, which are responsible for the recruitment, screening and selection of medical students. I have reviewed grants for the National Institutes of Health for over 15 years, in a spectrum of different study sections. I am the senior editor of CNS Oncology and a reviewer for over 25 academic journals. I serve on the advisory board of a number of organizations, including Voices Against Brain Cancer, the Tug McGraw Foundation, Pinnacle Care, the Pediatric Brain Tumor Foundation, the National Children’s Cancer Society, and the American Brain Tumor Association. Dr. Friedman is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.
Duke Cancer Center
I am an adult neurologist with further specialization in neuro-oncology. I treat adult patients with central nervous system (CNS) tumors of the brain and spine. My focus is combining compassionate patient-centered care with cutting-edge research. I want my patients to not only live longer, but also live better. I encourage my patients to be open and honest with me about their symptoms so I can find ways to help them feel better while undergoing treatment. What I love most about my job is seeing the courage and strength exhibited by my patients and their families. Dr. Johnson is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Brain Tumor, Astrocytoma, Glioblastoma, and Glioma.
Duke Cancer Center
Nursing is the only thing I have seriously thought of doing. It is a privilege to work with patients and families at a vulnerable time in their life. I am driven to help them in any capacity that I can. Outside of work, my husband Chad and kids, Hunter and Libby, motivate me to be the best I can. They are the light of my life. I enjoy cooking, the beach, watching football, and hosting weekend get together with friends. Go Hawkeyes!. Ms. Lally is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Congenital Cardiovascular Shunt, Normal Pressure Hydrocephalus, Hydrocephalus, and Pituitary Tumor.
Duke Health Integrated Practice Inc
David Ashley is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Ashley is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri. Dr. Ashley is currently accepting new patients.
Duke Blood Cancer Center
I was drawn to the field of oncology because cancer is a terrifying diagnosis for most people. It is one of those health issues that make people very nervous. I find great satisfaction working with cancer patients to help allay their fears and provide the best care possible. For me, it is rewarding to work with individuals who express so much courage in overcoming a difficult diagnosis. It is very rare that a patient comes alone to an appointment. Usually they have a spouse, son or daughter, a brother or sister, or a mother or father accompanying them. I spend a lot of time answering family member’s questions, who often provide a significant amount of care and support for their loved one. My job is to help educate both the patient and the family and to formulate a plan by which we can provide comprehensive care for all of the patient’s needs. Dr. Kelsey is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC).
Duke Health Integrated Practice Inc
John Barr is a Neurosurgery specialist and a Neurologist in Durham, North Carolina. Dr. Barr is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Klippel-Feil Syndrome, Subdural Hematoma, Spinal Stenosis, Laminectomy, and Microdiscectomy. Dr. Barr is currently accepting new patients.
Jennifer Garst is a Hematologist Oncology provider in Durham, North Carolina. Dr. Garst is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Garst is currently accepting new patients.
Paul Marcom is a Hematologist Oncology provider in Durham, North Carolina. Dr. Marcom is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Breast Cancer in Men.
James Vredenburgh is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Vredenburgh is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, Brain Tumor, and Bone Marrow Aspiration.
Duke Cancer Center
I am a part of the thoracic oncology program. I work with patients who have cancers of the lung, which includes non-small cell lung cancer, small cell lung cancer, and mesothelioma. My focus is on clinical care, clinical trials, and developing new therapies for these diseases. When I first meet with a patient, I want them to understand what their diagnosis is, because there are actually multiple diagnoses of lung cancer and each are treated differently. Then I discuss with a patient whether they are a candidate for therapies such as molecular therapy or immunotherapy, and make sure they have a clear understanding of the treatment plan. There are some very promising new therapies for these diseases and we are fortunate to have those available to patients here at Duke. That’s one of the unique things we offer as an academic medical center. Dr. Stinchcombe is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Gamma Knife Radiosurgery.
Duke Cancer Center Radiation Oncology
I am a radiation oncologist specializing in the treatment of head and neck cancers. I am passionate about helping patients to navigate the life changes surrounding the diagnosis and treatment for head and neck cancers. I chose a career in oncology because I empathize with patients and families owing to my own, close, family member's journey with cancer. My research interests include investigating new ways to make head and neck radiation better-tolerated. In my free time, I enjoy spending time with family and friends, trying new foods, and watching cat videos. Dr. Yu is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Astrocytoma, Glioblastoma, Neuroepithelioma, and Atypical Teratoid Rhabdoid Tumor (ATRT).
Duke Cancer Center
When someone is faced with a diagnosis of lung cancer, they may be going through surgery, radiation treatment, chemotherapy or enrolling in a clinical trial. It’s a very complicated process to understand what’s involved and what may happen next. It’s also hard to hear all the answers if you’re by yourself. We encourage our patients to come with family members and friends and loved ones and particularly to identify one or two main go-to people in terms of care-giving and support. That way we can engage them in the whole process. Just as we have a team taking care of the patient, the patient has a team, too. At Duke, we have the opportunity to engage patients in the very latest treatment approaches, whether it’s a new surgical technique, the latest radiation approach, or some novel chemotherapy, immunology, or targeted therapy, several of which we’ve been developing. Duke provides patients with a real opportunity that they may not have elsewhere. Dr. Crawford is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
Duke Cancer Center
I am a radiation oncologist, and I primarily focus on treating patients with cancer of the brain, lung, and spine. I find great satisfaction meeting with patients and working to provide the best care possible. During our visits, I enjoy getting to know patients and their families and learning about their hobbies, interests, and values. Working together, my goal is provide the tools and understanding so that they feel comfortable in making treatment decisions. I have the privilege of being a part of an excellent team of doctors, nurses, therapists, and treatment planners, who all work to design and carry out a personalized treatment plan for each patient. Outside of the clinic, I enjoy spending time with my family and friends. Dr. Mullikin is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, Large-Cell Lung Carcinoma, and Lung Adenocarcinoma.
Last Updated: 10/30/2025












